Enhanced glycolysis contributes to the chemotherapy resistance of colorectal cancer (CRC).
However, whether tRNA-derived small RNAs (tsRNAs) regulate CRC oxaliplatin sensitivity through glycolysis-mediated histone lactylation remains unclear.
